Loading clinical trials...
Loading clinical trials...
Multicenter, Double-Blind, Active Comparator-controlled Study to Evaluate the Safety and Efficacy of MK0507A in Patients With Glaucoma and Ocular Hypertension Who Are Inadequately Controlled on Beta-Blockers
Conditions
Interventions
dorzolamide hydrochloride (+) timolol maleate
Comparator: timolol maleate
+1 more
Start Date
March 12, 2007
Primary Completion Date
February 16, 2008
Completion Date
February 16, 2008
Last Updated
June 20, 2017
NCT07539675
NCT06289491
NCT07496957
NCT04354545
NCT07455786
NCT07298356
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions